commens
microb
increasingli
recogn
control
system
immun
homeostasi
respons
sinc
greatest
densiti
commens
bacteria
resid
within
intestin
tract
estim
trillion
organ
compris
individu
symbiot
relationship
commens
microb
mammalian
host
appropri
extens
character
tissu
accumul
evid
show
enter
commens
bacteria
play
import
role
maintain
local
immun
homeostasi
along
digest
nutrient
turn
disrupt
composit
intestin
bacteria
repres
import
iatrogen
caus
diarrhea
antibiot
use
infect
treatment
although
microbi
culprit
case
unidentifi
classic
exampl
toxininduc
intestin
inflamm
clostridium
difficil
overgrowth
among
antibiot
expos
disrupt
intestin
microbiota
composit
similarli
occur
among
individu
ulcer
coliti
crohn
communic
aberr
intestin
inflamm
genet
nonsuscept
host
reinforc
immun
regulatori
properti
enter
commens
thu
among
healthi
individu
commens
intestin
microb
immun
cell
sustain
delic
crosstalk
silenc
patholog
inflamm
simultan
preserv
host
defens
enter
pathogen
given
system
distribut
intestin
bacteria
structur
remark
perhap
surpris
commens
bacteria
also
shown
regul
system
inflamm
immun
respons
varieti
extraintestin
tissu
exampl
shift
abund
intestin
bacteroidet
firmicut
spp
link
human
obes
increas
bodi
fat
accumul
anim
transmiss
skew
microbiota
reinforc
caus
role
commens
bacteri
similarli
germ
free
compar
convent
hous
mice
suscept
genet
background
readili
develop
autoimmun
diabet
wherea
intestin
recolon
commens
microb
attenu
diseas
induc
toler
pancreasspecif
convers
autoimmun
disord
rheumatoid
arthriti
experiment
autoimmun
encephalomyel
stem
patholog
respons
commens
bacteria
particular
segment
filament
bacteria
play
detriment
thu
commens
bacteria
potent
regul
activ
system
immun
compon
benefici
harm
impact
autoimmun
extraintestin
tissu
commens
bacteria
shown
play
equal
pivot
role
regard
suscept
pathogen
microb
system
extraintestin
infect
caus
virus
commens
bacteria
appear
uniformli
protect
augment
host
defens
studi
use
viral
infect
probe
immun
shift
follow
antibiot
induc
erad
commens
bacteria
consist
show
blunt
expans
protect
viru
specif
cell
along
impair
clearanc
influenza
respiratori
tract
viremia
caus
lymphocyticchoriomening
find
may
explain
clinic
observ
antibiot
associ
suscept
viral
respiratori
allevi
viral
gastroenter
importantli
howev
sinc
virus
natur
resist
antibiot
use
erad
commens
bacteria
wide
util
probe
shift
host
defens
follow
commens
bacteria
elimin
extens
protect
benefit
pathogen
type
remain
undefin
nonetheless
repres
critic
import
question
consid
immun
compon
bolster
commens
microb
protect
virus
either
dispens
eg
cell
play
inconsist
role
eg
antifung
immun
accordingli
investig
commens
bacteria
control
respons
immun
compon
protect
system
fungal
infect
impact
commens
bacteria
erad
suscept
intraven
candida
albican
infect
evalu
surprisingli
show
erad
commens
bacteria
bolster
antifung
immun
enhanc
system
neutrophil
expans
enrich
accumul
infect
tissu
sharp
contrast
diminish
resist
viral
pathogen
thu
find
establish
fundament
discord
role
commens
bacteria
regul
antifung
compar
antivir
immun
investig
commens
intestin
microbiota
influenc
antifung
host
defens
suscept
c
albican
evalu
mice
administ
combin
antibiot
drink
water
ampicillin
gentamicin
metronidazol
neomycin
vancomycin
previous
shown
deplet
enter
commens
initi
studi
confirm
valid
approach
recover
bacteria
aerob
anaerob
growth
condit
becam
uniformli
elimin
fece
antibiot
treat
compar
control
mice
maintain
autoclav
drink
water
figur
moreov
antibiot
collect
impact
c
albican
growth
cell
free
broth
media
figur
illustr
potenti
differ
host
suscept
follow
antibiot
administr
reflect
shift
antifung
immun
consist
restrict
pathogen
distribut
describ
intraven
c
albican
recover
fungi
found
almost
exclus
within
kidney
sporad
coloni
recov
tissu
includ
brain
liver
spleen
regardless
antibiot
treatment
figur
interestingli
progress
increas
fungal
pathogen
burden
found
commens
bacteria
replet
control
mice
maintain
autoclav
drink
water
first
day
infect
recover
c
albican
declin
among
antibiot
treat
mice
begin
day
fungal
pathogen
burden
reduc
compar
control
mice
day
postinfect
figur
significantli
improv
overal
surviv
parallel
reduct
c
albican
pathogen
burden
commens
bacteria
erad
mice
surviv
among
antibiot
treat
compar
surviv
among
control
mice
p
figur
thu
antibiot
induc
erad
commens
bacteria
augment
protect
dissemin
c
albican
infect
given
pivot
import
neutrophil
mobil
recruit
host
defens
c
potenti
differ
immun
cell
subset
evalu
c
albican
intraven
inocul
among
antibiot
treat
compar
control
mice
start
compar
level
prior
infect
expans
neutrophil
blood
accumul
within
kidney
significantli
increas
begin
day
infect
commens
bacteria
erad
mice
figur
b
higher
neutrophil
level
found
blood
kidney
antibiot
treat
compar
control
mice
despit
reduc
c
albican
pathogen
burden
day
postinfect
figur
b
quantit
immun
cell
shift
appear
limit
neutrophil
proport
inflammatori
monocyt
b
cell
well
cell
differ
significantli
among
antibiot
treat
compar
control
mice
supplementari
figur
enumer
absolut
cell
number
verifi
neutrophil
expans
pronounc
compar
immun
cell
subset
intraven
c
albican
infect
regardless
commens
bacteria
deplet
figur
thu
enhanc
protect
c
albican
infect
antibiot
induc
erad
commens
bacteria
associ
enhanc
peripher
neutrophil
expans
mobil
cell
infect
tissu
along
enhanc
quantit
neutrophil
expans
among
antibiot
treat
compar
commens
bacteria
replet
control
mice
potenti
qualit
shift
activ
also
investig
enrich
neutrophil
use
neg
select
cell
could
routin
isol
peripher
blood
puriti
figur
allow
antifung
capac
compar
among
group
c
albican
infect
mice
despit
acceler
c
albican
clearanc
among
antibiot
treat
mice
infect
vivo
figur
neutrophil
isol
commens
bacteria
deplet
control
mice
compar
fungicid
activ
per
cell
basi
postinfect
time
point
figur
turn
express
molecul
associ
neutrophil
activ
includ
autocrin
product
express
upstream
transcript
regul
oxid
burst
shift
significantli
among
neutrophil
commens
bacteria
deplet
compar
control
mice
supplementari
figur
similarli
express
elastas
myeloperoxidas
associ
extracellular
trap
format
neutrophil
antifung
compar
among
neutrophil
regardless
antibiot
treatment
figur
wherea
product
extracellular
trap
effector
slightli
increas
among
cell
commens
bacteria
deplet
mice
figur
collect
result
show
robust
quantit
expans
neutrophil
unleash
erad
commens
bacteria
coincid
obviou
shift
fungicid
properti
per
cell
basi
occur
minim
qualit
shift
cell
activ
definit
investig
protect
role
neutrophil
expand
enrich
level
commens
bacteria
erad
impact
deplet
cell
c
albican
suscept
evalu
antibiot
treat
compar
commens
bacteria
replet
control
mice
sinc
reduc
pathogen
recoveri
improv
surviv
among
commens
bacteria
erad
mice
becom
appar
begin
day
infect
exagger
differ
pathogen
recoveri
day
postinfect
figur
neutrophil
deplet
initi
day
infect
impact
pathogen
burden
enumer
day
thereaft
studi
util
clone
antimous
antibodi
spare
inflammatori
monocyt
allow
contribut
neutrophil
evalu
despit
somewhat
reduc
effici
cell
deplet
compar
report
infect
pathogen
caus
acut
consist
deplet
neutrophil
expand
level
antibiot
treat
mice
still
suffici
overrid
reduct
fungal
burden
confer
commens
bacteria
erad
figur
b
particular
c
albican
recov
antibiot
treat
mice
administ
compar
isotyp
control
antibodi
figur
compar
signific
differ
recover
fungal
pathogen
burden
found
antibodi
among
commens
bacteria
replet
mice
dampen
neutrophil
expans
figur
b
interestingli
increas
c
albican
pathogen
burden
neutrophil
deplet
among
antibiot
treat
mice
associ
signific
differ
overal
surviv
like
substanti
proport
isotyp
antibodi
treat
mice
alreadi
begun
succumb
day
post
infect
neutrophil
deplet
initi
figur
circumv
limit
relat
experi
track
surviv
separ
group
mice
administ
compar
isotyp
control
antibodi
day
intraven
c
albican
infect
mice
becam
moribund
succumb
infect
analysi
show
neutrophil
deplet
initi
earlier
infect
elimin
protect
confer
commens
bacteria
erad
antibiot
treat
control
mice
succumb
rapidli
similar
acceler
kinet
figur
thu
enhanc
protect
dissemin
c
albican
infect
unleash
erad
intestin
commens
bacteria
requir
enrich
neutrophil
expans
given
appar
suscept
system
c
albican
infect
confer
commens
intestin
bacteria
specif
investig
potenti
shift
enter
bacteri
densiti
follow
dissemin
fungal
infect
sinc
c
albican
establish
colon
intestin
lumen
follow
system
first
evalu
whether
enter
bacteria
retain
among
mice
without
antibiot
treatment
c
albican
infect
discrimin
bacteria
c
albican
microbi
growth
fecal
pellet
plate
media
without
antibiot
supplement
compar
media
supplement
cocktail
antibiot
ampicillin
gentamicin
metronidazol
neomycin
vancomycin
ad
drink
water
combin
antibiot
prevent
growth
commens
bacteria
accordingli
microbi
recoveri
antibiot
supplement
media
repres
enter
c
albican
growth
nonsuppl
media
reflect
cumul
bacteri
plu
fungal
commens
burden
expect
fece
mice
maintain
drink
water
without
antibiot
supplement
contain
exclus
commens
bacteria
fecal
organ
could
recov
antibiot
treat
mice
prior
c
albican
infect
figur
compar
c
albican
intraven
infect
antibiot
treat
mice
devoid
commens
bacteria
becam
dens
colon
fungi
compar
high
fecal
cfu
recov
regardless
antibiot
supplement
cultur
media
figur
contrast
commens
burden
c
albican
infect
mice
without
antibiot
supplement
drink
water
bacteri
cfusg
recov
media
without
antibiot
supplement
becam
reduc
cfusg
antibiot
supplement
media
figur
thu
dissemin
c
albican
infect
significantli
impact
densiti
commens
intestin
bacteria
among
mice
without
antibiot
treatment
consid
drastic
differ
commens
intestin
bacteria
densiti
among
antibiot
treat
compar
control
mice
occur
regardless
c
albican
infect
compon
enter
bacteria
confer
suscept
dissemin
fungal
infect
commens
bacteria
replet
mice
investig
sinc
lp
commens
bacteria
shown
confer
protect
viral
address
whether
compon
enter
bacteria
reciproc
respons
confer
suscept
fungal
infect
found
reconstitut
mice
erad
commens
bacteria
lp
restor
suscept
system
c
albican
infect
significantli
reduc
surviv
reciproc
increas
fungal
pathogen
burden
recov
increas
concentr
intrarect
lp
administr
figur
c
erad
commens
intestin
bacteria
essenti
detriment
properti
exogen
lp
commens
bacteria
replet
mice
show
signific
differ
surviv
even
highest
dosag
intrarect
lp
supplementari
figur
taken
togeth
result
demonstr
lp
compon
commens
intestin
bacteria
confer
suscept
dissemin
c
albican
infect
addit
experi
perform
investig
immunolog
basi
enhanc
antifung
immun
compar
diminish
protect
viral
pathogen
previous
describ
use
combin
antibiot
erad
commens
intestin
first
address
possibl
differ
commens
bacteria
composit
research
institut
may
influenc
immun
cell
impact
commens
bacteria
erad
antivir
immun
influenza
viru
infect
evalu
specif
pathogen
free
facil
infect
subleth
dose
recombin
influenza
stabli
express
immunedomin
ovalbumin
ova
significantli
weight
loss
recoveri
viral
plaqu
form
unit
lung
homogen
found
antibiot
treat
compar
commens
bacteria
replet
control
mice
figur
b
enhanc
suscept
influenza
among
commens
bacteria
deplet
mice
parallel
sharp
reduct
expans
ovaspecif
cell
surrog
viral
specif
figur
thu
protect
benefit
commens
bacteria
antivir
immun
previous
report
use
influenza
strain
infect
mice
hous
research
facil
consid
protect
c
albican
enhanc
accumul
neutrophil
erad
commens
bacteria
figur
result
suggest
discord
antifung
compar
antivir
immun
confer
commens
intestin
bacteria
like
reflect
fundament
differ
commens
microb
control
activ
uniqu
immun
compon
protect
infect
viral
rather
fungal
pathogen
investig
hypothesi
role
commens
intestin
bacteria
expans
cell
infect
recombin
c
albican
engin
express
peptid
remark
near
ident
reduct
expans
ovaspecif
cell
among
commens
bacteria
deplet
mice
observ
infect
recombin
c
albican
compar
influenza
figur
thu
commens
bacteria
uniformli
promot
antigenspecif
cell
expans
regardless
incit
pathogen
type
simultan
restrict
optim
accumul
neutrophil
taken
togeth
result
demonstr
commens
bacteria
differenti
regul
activ
uniqu
immun
cell
subset
turn
caus
discord
impact
antifung
compar
antivir
immun
commens
microb
increasingli
recogn
influenc
respons
immun
cell
dictat
suscept
autoimmun
infect
sinc
virus
inher
resist
antibiot
shift
host
defens
follow
commens
bacteria
elimin
primarili
probe
viral
pathogen
commens
bacteria
shown
play
import
somewhat
discord
role
regard
infect
suscept
exampl
antibiot
induc
erad
commens
intestin
bacteria
consist
impair
host
clearanc
influenza
viru
within
respiratori
tract
prolong
viremia
system
lymphocyt
choriomening
viru
diminish
viral
clearanc
instanc
parallel
reduc
prime
expans
protect
virusspecif
cell
commens
bacteria
erad
hand
presenc
commens
intestin
bacteria
also
promot
suscept
numer
enter
virus
includ
polioviru
retroviru
mous
mammari
tumor
viru
exploit
bacteri
lp
improv
transmiss
latter
enhanc
capac
intestin
invas
replic
confer
commens
bacteria
reflect
direct
viral
modul
enter
virus
oppos
system
shift
inflammasom
macrophag
cell
activ
occur
infect
influenza
lymphocyt
choriomening
viru
accordingli
extend
applic
find
system
immun
pathogen
equal
ubiquit
clinic
import
resist
antibiot
impact
commens
bacteria
erad
antifung
immun
investig
use
establish
murin
model
dissemin
c
albican
surprisingli
strike
contrast
protect
benefit
system
antivir
immun
show
commens
bacteria
collect
confer
detriment
impact
antifung
host
defens
among
antibiot
treat
mice
deplet
intestin
commens
bacteria
significantli
reduc
c
albican
fungal
burden
increas
overal
surviv
observ
compar
commens
bacteria
replet
control
mice
importantli
find
explain
differ
commens
bacteria
composit
mice
across
institut
consid
antivir
protect
benefit
commens
intestin
bacteria
previous
reproduc
influenza
infect
mice
maintain
facil
thu
commens
microb
differenti
regul
uniqu
immun
cell
subset
control
antifung
compar
antivir
immun
protect
dissemin
c
albican
infect
among
commens
bacteria
erad
mice
reflect
reduc
intestin
lp
content
exogen
intrarect
lp
administr
restor
suscept
dose
depend
fashion
consid
context
candida
overgrowth
mucos
interfac
antibiot
administr
may
reflect
elimin
microb
compet
limit
local
commens
bacteria
deriv
polysaccharid
sustain
cell
activ
restrict
fungal
protect
invas
system
candidiasi
specif
mediat
find
may
explain
probiot
supplement
preterm
neonat
reduc
incid
gastrointestin
fungal
colon
without
amelior
suscept
invas
system
fungal
reciproc
neutropenia
consist
identifi
domin
independ
risk
factor
dissemin
candidiasi
fungal
infectioninduc
thu
link
enrich
neutrophil
expans
protect
intraven
c
albican
infect
demonstr
use
antibiot
erad
enter
commens
bacteria
reinforc
domin
role
neutrophil
play
immun
system
candidiasi
sinc
immun
compon
mediat
antifung
compar
antivir
immun
larg
nonoverlap
newfound
discord
commens
bacteria
collect
control
host
defens
type
pathogen
perhap
unexpect
exampl
cell
confer
protect
influenza
viru
pathogen
primarili
resid
within
intracellular
compart
infect
host
cell
play
neglig
role
protect
c
albican
mainli
resid
extracellular
nonessenti
role
pathogenspecif
cell
host
defens
fungi
like
c
albican
consist
result
illustr
acceler
fungal
clearanc
despit
blunt
expans
cell
surrog
c
albican
specif
among
commens
bacteria
deplet
mice
instead
show
enhanc
antifung
immun
antibiot
induc
commens
bacteria
erad
reflect
robust
neutrophil
expans
mobil
wherea
even
partial
neutrophil
deplet
antibodi
clone
overrid
protect
benefit
compar
among
commens
bacteria
replet
mice
detriment
impact
neutrophil
deplet
moder
potenti
revers
sinc
initi
neutrophil
deplet
day
infect
improv
surviv
although
differ
reach
statist
signific
p
result
parallel
somewhat
paradox
detriment
role
neutrophil
shown
use
lossoffunct
approach
cell
dissemin
candidiasi
alreadi
establish
exampl
initi
neutrophil
togeth
monocyt
eosinophil
deplet
use
antibodi
clone
day
intraven
c
albican
infect
significantli
improv
overal
similarli
mice
impair
neutrophil
accumul
kidney
begin
day
postinfect
improv
overal
surviv
intraven
c
albican
infect
compar
wildtyp
control
thu
neutrophil
clearli
import
protect
earli
dissemin
accumul
later
fungal
infect
like
caus
immun
patholog
similar
increas
mortal
robust
neutrophil
expans
influenza
taken
togeth
data
suggest
commens
bacteria
control
expans
specif
immun
cell
subset
dictat
whether
increas
suscept
resist
ensu
shift
composit
densiti
may
influenc
tempo
persist
infect
well
first
glanc
result
may
also
appear
contradictori
clinic
associ
antibiot
exposur
risk
fungemia
c
albican
candida
howev
also
import
highlight
coexist
perhap
formid
risk
factor
includ
intravascular
catheter
diabet
mellitu
mechan
ventil
underli
malign
drive
use
antimicrobi
among
individu
immun
compromis
condit
confer
suscept
bacteri
fungal
furthermor
result
use
oral
administ
broadspectrum
antibiot
design
erad
commens
intestin
bacteria
near
complet
may
directli
applic
clinic
use
antibiot
design
treat
prevent
bacteri
infect
dysbiosi
disrupt
composit
commens
bacteria
inevit
sideeffect
particular
use
antibiot
clinic
set
almost
certainli
elimin
intestin
bacteria
near
complet
therefor
although
find
attribut
impair
antifung
immun
presenc
bacteri
lp
commens
microb
replet
mice
shift
composit
commens
intestin
bacteria
like
also
play
critic
role
modul
suscept
fungemia
notion
support
observ
commens
bacteri
speci
segment
filament
bacteria
drive
system
cell
turn
stimul
optim
neutrophil
mobil
immun
extracellular
pathogen
includ
c
reciproc
may
explain
wide
use
antibiot
includ
cephalosporin
penicillin
vancomycin
potent
activ
segment
filament
bacteria
independ
associ
increas
risk
base
result
increas
use
antibiot
clinic
medicin
identifi
essenti
commens
microbiom
subset
repres
import
next
step
dissect
antifung
compar
antivir
immun
discordantli
regul
mice
purchas
nation
cancer
institut
tcr
transgen
mice
maintain
congen
background
enumer
ovaspecif
cell
splenocyt
transgen
mice
maintain
congen
background
adopt
transfer
recipi
mice
one
day
prior
infect
indic
time
point
infect
recombin
c
albican
recombin
influenza
express
ova
cell
surrog
pathogen
specif
identifi
base
express
mice
maintain
specif
pathogen
free
condit
cincinnati
children
hospit
use
accord
institut
iacuc
approv
protocol
antibiot
cocktail
use
erad
commens
bacteria
briefli
drink
water
supplement
ampicillin
mgml
sigma
gentamicin
mgml
sigma
metronidazol
mgml
sigma
neomycin
mgml
sigma
vancomycin
mgml
mp
biomed
suraclos
sigma
antibiot
supplement
initi
week
prior
infect
continu
durat
experi
recombin
c
albican
strain
express
infect
c
albican
cultur
day
prior
ypad
media
rpm
follow
day
cultur
back
dilut
fresh
ypad
media
hour
reach
exponenti
phase
growth
fungi
wash
resuspend
steril
salin
age
sexmatch
mice
given
intraven
tailvein
inject
cfu
pb
influenza
viru
express
peptid
dilut
pfusml
administ
intranas
mice
anesthet
xylazin
indic
time
point
c
albican
inocul
kidney
spleen
liver
brain
steril
dissect
homogen
serial
dilut
organ
homogen
spread
onto
agar
plate
incub
hour
fungal
coloni
form
unit
enumer
influenza
infect
lung
collect
homogen
viral
titer
enumer
count
viral
plaqu
form
serial
dilut
lung
homogen
plate
onto
confluent
madindarbi
canin
kidney
mdck
cell
kidney
minc
piec
digest
mgml
collagenas
sigma
mgml
dnase
sigma
mgml
dispas
stemcel
technolog
minut
rpm
thereaft
solut
filter
mesh
supernat
pellet
rpm
minut
enrich
percol
gradient
kidney
leukocyt
collect
analyz
fac
blood
obtain
retroorbit
sinu
immedi
place
heparin
tube
wash
pb
follow
rbc
lysi
buffer
mm
mm
ph
prior
fac
analysi
fluorophoreconjug
antibodi
use
flow
cytometri
includ
biolegend
ebiosci
ebiosci
biolegend
ebiosci
ebiosci
ebiosci
ebiosci
bd
bioscienc
ebiosci
ebiosci
neutrophil
deplet
purifi
bioxcel
isotyp
rat
bioxcel
antibodi
administ
intraperiton
inject
day
c
albican
infect
sustain
dose
everi
three
day
thereaft
neutrophil
isol
peripher
blood
neg
select
use
magnet
bead
cell
isol
kit
miltenyi
biotec
puriti
cell
verifi
fac
analysi
quantifi
myeloperoxidas
activ
neutrophil
seed
plate
incub
aminophenyl
fluorescein
sigma
hour
room
temperatur
product
fluoresc
product
fluorescein
reflect
myeloperoxidas
activ
measur
use
plate
reader
nm
excit
nm
emiss
elastas
assay
perform
incub
purifi
neutrophil
bodipi
conjug
elastin
life
technolog
minut
thereaft
fluoresc
intens
elastas
product
bodipi
measur
flow
cytometri
measur
calprotectin
secret
purifi
neutrophil
resuspend
dmem
life
technolog
incub
minut
thereaft
supernat
collect
analyz
elisa
accord
manufactur
instruct
hycult
biotech
vitro
neutrophil
kill
assay
perform
previous
briefli
peripher
blood
neutrophil
purifi
neutrophil
incub
cfu
c
albican
moi
hour
gentl
agit
round
bottom
plate
thereaft
c
albican
cfu
enumer
spread
serial
dilut
cocultur
mixtur
agar
plate
percent
kill
candida
defin
cfu
incubationcfu
recov
start
incub
dihydrorhodamin
assay
leukocyt
seed
round
bottom
plate
media
supplement
dihydrorhodamin
final
concentr
per
well
incub
minut
thereaft
fluoresc
intens
rhodamin
illustr
oxid
burst
potenti
measur
flow
mice
anesthet
xylazin
ketamin
intrarect
inocul
indic
dosag
ultrapur
escherichia
coli
lp
invivogen
resuspend
steril
salin
begin
two
day
prior
c
albican
infect
repeat
dose
everi
two
day
thereaft
differ
surviv
compar
use
log
rank
mantelcox
test
cell
frequenc
enzymat
activ
protein
secret
analyz
unpair
student
test
differ
pathogen
burden
compar
nonparametr
mannwhitney
test
two
group
nonparametr
kruskalw
oneway
anova
two
group
case
p
taken
statist
signific
